Intracranial atherosclerosis: current understanding and perspectives.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 3961814)

Published in J Stroke on January 31, 2014

Authors

Oh Young Bang1

Author Affiliations

1: Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Associated clinical trials:

PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis (PINNACLE) | NCT03507374

Articles cited by this

High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79

Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med (2011) 12.76

Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke (2010) 10.66

Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med (2005) 7.92

Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke (1995) 4.54

Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation (2006) 4.21

Global burden of intracranial atherosclerosis. Int J Stroke (2006) 2.98

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol (2010) 2.97

Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke (2008) 2.68

Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62

Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study. Stroke (2007) 2.55

Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology (2005) 2.45

Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology (2006) 2.28

Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One (2011) 2.01

Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology (2007) 1.97

A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet (2010) 1.97

In vivo high-resolution MR imaging of symptomatic and asymptomatic middle cerebral artery atherosclerotic stenosis. Atherosclerosis (2010) 1.90

Intracranial atherosclerotic disease: an update. Ann Neurol (2009) 1.86

Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol (1999) 1.81

Low-molecular-weight heparin compared with aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol (2007) 1.79

Circulating endothelial microparticles as a marker of cerebrovascular disease. Ann Neurol (2009) 1.76

Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke (2009) 1.75

Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol (2002) 1.64

Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials. Lancet Neurol (2013) 1.62

Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke (2005) 1.58

Race-ethnic differences in stroke risk factors among hospitalized patients with cerebral infarction: the Northern Manhattan Stroke Study. Neurology (1995) 1.55

Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis. J Neurol Neurosurg Psychiatry (2005) 1.52

CVD risk factors and ethnicity--a homogeneous relationship? Atheroscler Suppl (2006) 1.50

Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke (2001) 1.40

Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke (2008) 1.36

Intracranial atherosclerotic plaque enhancement in patients with ischemic stroke. AJNR Am J Neuroradiol (2012) 1.34

Secular trends in ischemic stroke characteristics in a rapidly developed country: results from the Korean Stroke Registry Study (secular trends in Korean stroke). Circ Cardiovasc Qual Outcomes (2012) 1.34

Critique of "Stenting versus aggressive medical therapy for intracranial arterial stenosis" by Chimowitz et al in the new England Journal of Medicine. Stroke (2012) 1.32

Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)? Stroke (2012) 1.28

Middle cerebral artery stenosis is a major clinical determinant in striatocapsular small, deep infarction. Arch Neurol (2002) 1.23

Progression of middle cerebral artery occlusive disease and its relationship with further vascular events after stroke. Stroke (2002) 1.20

Natural history of stenosis from intracranial atherosclerosis by serial angiography. Stroke (1998) 1.18

Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis (2009) 1.13

Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. Neurol Med Chir (Tokyo) (2012) 1.13

Intracranial carotid artery atherosclerosis: prevalence and risk factors in the general population. Stroke (2012) 1.10

Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology (2007) 1.10

A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prev Med (2009) 1.08

Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese. Eur J Neurol (2005) 1.06

Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology (2006) 1.05

Risk factors associated with severity and location of intracranial arterial stenosis. Stroke (2010) 1.05

Prevalence and risk factors of middle cerebral artery stenosis in asymptomatic residents in Rongqi County, Guangdong. Cerebrovasc Dis (2007) 1.05

A door-to-door survey of intracranial atherosclerosis in Liangbei County, China. Neurology (2007) 1.05

Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome. Int J Mol Med (2008) 1.05

Risk factors of intracranial cerebral atherosclerosis among asymptomatics. Cerebrovasc Dis (2007) 1.03

Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke (2011) 1.03

Plaque distribution of stenotic middle cerebral artery and its clinical relevance. Stroke (2011) 1.02

Pathology of cerebral atherosclerosis. Influence of age, race, and gender. Stroke (1993) 0.99

Geographic and sex difference in the distribution of intracranial atherosclerosis in China. Stroke (2013) 0.99

Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke (2008) 0.97

Diversity of single small subcortical infarctions according to infarct location and parent artery disease: analysis of indicators for small vessel disease and atherosclerosis. Stroke (2010) 0.97

Prevalence and risk factors of intracranial atherosclerosis in an asymptomatic korean population. J Clin Neurol (2006) 0.96

Cilostazol, not aspirin, reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats. Stroke (2011) 0.96

Single subcortical infarction and atherosclerotic plaques in the middle cerebral artery: high-resolution magnetic resonance imaging findings. Stroke (2013) 0.96

Biological signatures of asymptomatic extra- and intracranial atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial Atherosclerosis) study. Stroke (2012) 0.95

Middle cerebral artery plaque and prediction of the infarction pattern. Arch Neurol (2012) 0.94

Infarct patterns in atherosclerotic middle cerebral artery versus internal carotid artery disease. Neurology (2004) 0.92

Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study. Arch Neurol (2005) 0.92

Adiponectin levels in patients with intracranial atherosclerosis. Neurology (2007) 0.91

Treatment of atherosclerotic intracranial arterial stenosis. Stroke (2009) 0.89

A possible explanation for the racial difference in distribution of large-arterial cerebrovascular disease: ancestral European settlers evolved genetic resistance to atherosclerosis, but confined to the intracranial arteries. Med Hypotheses (2005) 0.88

Branch occlusive disease: clinical and magnetic resonance angiography findings. Neurology (2012) 0.87

Prevalence and epidemiological features of moyamoya disease in Korea. J Cerebrovasc Endovasc Neurosurg (2012) 0.85

Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. Eur J Neurol (2007) 0.85

Short-term effect of atorvastatin on carotid artery elasticity: a pilot study. Stroke (2011) 0.84

Impact of metabolic syndrome on distribution of cervicocephalic atherosclerosis: data from a diverse race-ethnic group. J Neurol Sci (2009) 0.83

Intracranial atherosclerotic disease. Stroke Res Treat (2011) 0.83

Predictors of recurrent stroke in patients with symptomatic intracranial arterial stenosis. Stroke (2012) 0.82

Classic risk factors for atherosclerosis are not major determinants for location of extracranial or intracranial cerebral atherosclerosis. Neuroepidemiology (2009) 0.82

Stroke in Korean. Stroke (2008) 0.81

Intracranial atherosclerotic stroke: specific focus on the metabolic syndrome and inflammation. Curr Atheroscler Rep (2006) 0.80

Analysis of incidence and risk factors for progression in patients with intracranial steno-occlusive lesions by serial magnetic resonance angiography. Clin Neurol Neurosurg (2007) 0.80

Medical treatment of patients with intracranial atherosclerotic disease. J Neuroimaging (2009) 0.78

Associations of cigarette smoking with intracranial atherosclerosis in the patients with acute ischemic stroke. Clin Neurol Neurosurg (2012) 0.78

Articles by these authors

New oral anticoagulants may be particularly useful for asian stroke patients. J Stroke (2014) 1.00

Multimodal MRI for ischemic stroke: from acute therapy to preventive strategies. J Clin Neurol (2009) 0.89

Adult Moyamoya Disease: A Burden of Intracranial Stenosis in East Asians? PLoS One (2015) 0.84

Predicting stroke outcome using clinical- versus imaging-based scoring system. J Stroke Cerebrovasc Dis (2014) 0.83

Patent Foramen Ovale and Stroke-Current Status. J Stroke (2015) 0.83

Hypercoagulability and Mortality of Patients with Stroke and Active Cancer: the OASIS-CANCER Study. J Stroke (2016) 0.79

Lack of Association of Clinical Factors (SAMe-TT2R2) with CYP2C9/VKORC1 Genotype and Anticoagulation Control Quality. J Stroke (2015) 0.76

Association of Left Atrial Enlargement with Cortical Infarction in Subjects with Patent Foramen Ovale. J Stroke (2016) 0.75

Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants. J Stroke (2016) 0.75

Role of high-resolution magnetic resonance imaging in the diagnosis of primary angiitis of the central nervous system. J Clin Neurol (2014) 0.75

Response to letter regarding article, "high-resolution magnetic resonance wall imaging findings of Moyamoya disease". Stroke (2014) 0.75

Medical Treatment of Intracranial Atherosclerosis: An Update. J Stroke (2017) 0.75

Quality of Anticoagulation with Warfarin in Korean Patients with Atrial Fibrillation and Prior Stroke: A Multicenter Retrospective Observational Study. J Clin Neurol (2017) 0.75